Oncology screenings took a worrying downturn during the pandemic. Recent data shows an upward trend in oncology screenings across cancer types, with non-small cell lung cancer showing the most positive upward trend. This is encouraging data, but may be spurred by the current virus surge and fears of future restrictions to office hours or access to in person care.
You may also be interested in:
News
COVID-19 Weekly Trend Insights
Symphony Health is tracking the impact of COVID-19 across all therapeutic areas and US regions, and will be publishing these findings in our Weekly…
News
COVID-19 Weekly Trend Insights
Breast and cervical cancer screenings, post-partum appointments, and infertility treatments have all decreased dramatically in the last few months.…
News
COVID-19 Bi-Weekly Trend Insights
The COVID-19 patient group continually studied by PRA serves as a baseline to understand the demographics of patients receiving the vaccine. The…